Definitive Healthcare Corp. DH
- Market cap
- $146.3M
- P/E
- 0.0×
Follow DH
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 24.66 | 9.53 | 5.53 | 3.19 | 2.15 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | 50.30 | 30.11 | 14.03 | 10.62 | 5.68 |
High Price
|
|||
| — | — | — | — | 625 | 676 | 974 | 830 | 782 | 686 |
Employees
|
|||
| — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | 86 | 118 | 166 | 223 | 251 | 252 | 242 |
Revenue
|
|||
| — | — | — | 78.23% | 74.25% | 75.51% | 80.86% | 81.11% | 78.30% | 75.88% |
Gross Margin
|
|||
| — | — | — | (36) | (53) | (63) | (42) | (308) | (634) | (209) |
EBT
|
|||
| — | — | — | (42.57%) | (44.46%) | (37.78%) | (18.81%) | (122.58%) | (251.28%) | (86.64%) |
EBT Margin
|
|||
| — | 0 | — | (36) | (53) | (62) | (24) | (290) | (591) | (199) |
Net Income
|
|||
| — | — | — | 36 | 63 | 66 | 66 | 353 | 757 | 269 |
Depreciation
|
|||
| — | — | — | 0.57 | 1.22 | 1.81 | 2.20 | 2.23 | 2.16 | 2.26 |
Revenue/Sh
|
|||
| — | — | — | (0.24) | (0.34) | (0.68) | (0.06) | (1.79) | (3.54) | (1.30) |
Earnings/Sh
|
|||
| — | — | — | 0.14 | 0.24 | 0.27 | 0.35 | 0.37 | 0.50 | 0.50 |
Cash Flow/Sh
|
|||
| — | — | — | (0.01) | (0.01) | (0.07) | (0.08) | (0.03) | (0.11) | (0.16) |
Capex/Sh
|
|||
| — | — | — | 0.13 | 0.22 | 0.20 | 0.27 | 0.34 | 0.39 | 0.35 |
Free CF/Sh
|
|||
| — | — | — | 8.16 | 12.32 | 16.32 | 14.66 | 10.63 | 5.21 | 3.55 |
Book Value/Sh
|
|||
| — | — | — | 149 | 97 | 92 | 101 | 113 | 117 | 107 |
Shares
|
|||
| — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | 45.94 | 45.94 | 15.12 | 5.09 | 4.55 | 1.90 | 1.27 |
PS Ratio
|
|||
| — | — | — | 5.50 | 5.50 | 1.67 | 0.76 | 0.95 | 0.79 | 0.81 |
PB Ratio
|
|||
| — | — | — | 48.95 | 48.95 | 14.42 | 4.78 | 4.35 | 1.71 | 1.20 |
EV/Sales
|
|||
| — | — | — | 267.71 | 267.71 | 129.61 | 39.08 | 28.60 | 9.43 | 7.83 |
EV/FCF
|
|||
| — | — | — | 22 | 23 | 25 | 36 | 41 | 58 | 54 |
Op' Cash Flow
|
|||
| — | — | — | (2) | (1) | (7) | (8) | (3) | (12) | (17) |
Capex
|
|||
| — | — | — | 20 | 22 | 18 | 27 | 38 | 46 | 37 |
FCF
|
|||
| — | — | — | (34) | (25) | 321 | 273 | 223 | 209 | 101 |
Working Cap'
|
|||
| — | — | — | 439 | 462 | 271 | 264 | 256 | 243 | 165 |
Total Debt
|
|||
| — | — | — | 431 | 437 | (117) | (68) | (52) | (47) | (16) |
Net Debt
|
|||
| — | — | — | 1,216 | 1,196 | 1,500 | 1,482 | 1,199 | 607 | 379 |
Sh' Equity
|
|||
| — | — | — | 0.00% | (2.95%) | (0.92%) | (0.34%) | (10.25%) | (28.34%) | (15.23%) |
ROA
|
|||
| — | — | — | (0.68%) | (0.61%) | (1.23%) | (1.95%) | (17.96%) | (79.31%) | (38.62%) |
ROIC
|
|||
| — | — | — | 0.00% | (4.24%) | (1.32%) | (0.48%) | (15.10%) | (45.74%) | (28.18%) |
ROE
|
|||
Definitive Healthcare Corp. peers in Health Information Services
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| OPRX OptimizeRx Corp. | $148.6M | 33.4× | Compare |
| LFMD LifeMD, Inc. | $140.3M | 0.0× | Compare |
| HCAT Health Catalyst, Inc. | $131.0M | 0.0× | Compare |
| SPOK Spok Holdings, Inc. | $216.5M | 17.4× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| AMWL American Well Corporation | $229.1M | 0.0× | Compare |
| SY So-Young International Inc. Sponsored ADR | $229.5M | 0.0× | Compare |
| CCLD CareCloud, Inc. | $87.5M | 29.4× | Compare |
| DRIO DarioHealth Corp. | $66.3M | 0.0× | Compare |
Definitive Healthcare Corp. (DH) key facts
- Definitive Healthcare Corp. (DH) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
- Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.
- As of September 25, 2026, DH traded at $0.95, a market capitalization of $146.3 million.
- Return on equity was −28.2% and debt-to-equity 0.86.
Definitive Healthcare Corp. (DH) Latest News
2 Sep
Definitive Healthcare shares rose 13% after Advent International submitted a $1.02-per-share acquisition proposal. Acquisition proposal at $1.02 per share creates potential full takeover that redefines company ownership and long-term trajectory.
Definitive Healthcare Corp. board special committee confirms receipt of going-private proposal from Advent International. Going-private proposal signals major strategic shift likely to alter company ownership structure and market trajectory.
Definitive Healthcare Corp. appoints Clay Ritchey as CEO. CEO appointment can shift company strategy and operations but effects remain balanced by other factors.
17 Aug
Definitive Healthcare Corp. (DH) held its Q2 2026 earnings call. Q2 2026 earnings call provides financial results and outlook that can shift investor views and company trajectory.
11 Aug
Definitive Healthcare Corp. conducted its Q2 2026 earnings call covering financial results, operational updates, and forward guidance. Q2 2026 earnings results and guidance directly shape near-term stock movement and valuation.
Definitive Healthcare Corp (DH) launched an AI platform during its Q2 2026 earnings call, highlighting new product developments and operational updates. AI platform launch marks a major strategic move with potential to significantly alter company trajectory and investor sentiment.
10 Aug
Definitive Healthcare Corp. released Q2 earnings call highlights covering financial results and operational updates. Q2 earnings directly shape near-term valuation and guidance expectations for the company.
Definitive Healthcare Corp. (DH) reported Q2 earnings that beat analyst estimates. Q2 earnings beat indicates better-than-expected financial results likely to influence near-term stock performance.
Definitive Healthcare Corp. reported its financial results for the second quarter of 2026. Quarterly results update performance metrics that may shift short-term market views without altering long-term trajectory.
6 Aug
Definitive Healthcare launches early adopter program for new AI-powered healthcare intelligence platform. AI platform launch represents major product innovation with potential to shift competitive positioning and growth trajectory.
21 May
Definitive Healthcare Corp. advances its data platform and integrations to deliver smarter healthcare insights. Platform advancements and integrations may moderately enhance company offerings and positioning.
11 May
Analysts issued a financial statement on Definitive Healthcare Corp. (NASDAQ:DH)'s first-quarter report. Analyst commentary on Q1 financials moderately influences market sentiment and financial performance expectations.
7 May
Definitive Healthcare Corp. (DH) released Q1 earnings call highlights covering financial results, revenue growth, and strategic initiatives. Q1 earnings highlights detail financial performance and guidance that significantly shape investor sentiment and stock trajectory.
Definitive Healthcare Corp. (DH) released Q1 2026 earnings call summary detailing financial performance, guidance, and strategic updates. Earnings call summary reveals Q1 2026 financials and outlook, poised to significantly sway DH's trajectory and investor views.
Definitive Healthcare Corp. (DH) beat Q1 earnings estimates, delivering stronger-than-expected results. Beating Q1 earnings estimates boosts investor sentiment and signals robust financial performance.
Definitive Healthcare Corp. (DH) reported financial results for the first quarter of 2026. Quarterly earnings reports significantly impact stock performance and investor sentiment.
30 Apr
Analysts forecast Definitive Healthcare Corp. (DH) to report declining earnings, urging investors to monitor key metrics in the upcoming release. Forecasted earnings decline could moderately impact financial performance expectations and investor sentiment ahead of the report.
27 Feb
Definitive Healthcare Corp. (DH) released its earnings call transcript, covering executive discussions on financial results, performance highlights, and forward-looking guidance. Earnings transcripts disclose detailed financial metrics, strategic initiatives, and outlook that can substantially influence investor sentiment and stock trajectory.
Definitive Healthcare Corp. (DH) Q4 2025 earnings call summary highlights financial results, revenue growth, profitability metrics, and forward guidance for the healthcare data analytics firm. Q4 earnings call summary discloses key financials and outlook, significantly influencing stock price and investor expectations.
Definitive Healthcare Corp (DH) Q4 2025 earnings call highlights revenue challenges, with management navigating growth hurdles amid strategic adjustments. Revenue challenges disclosed in Q4 2025 earnings moderately influence financial performance and investor sentiment.
26 Feb
Definitive Healthcare Corp. (DH) released Q4 earnings call highlights, covering financial results, strategic updates, and forward guidance. Q4 earnings call highlights disclose financial performance, growth metrics, and future outlook that significantly influence DH's trajectory and investor sentiment.
Definitive Healthcare Corp. (DH) reported financial results for the fourth quarter and full fiscal year 2025. Reporting quarterly and annual financial results affects key financial performance metrics and market sentiment.
28 Jan
Definitive Healthcare Corp. (DH) is highlighted as a promising penny stock alongside two others. The article discusses the company's growth potential and market position, emphasizing its innovative healthcare data solutions and the increasing demand for analytics in the healthcare sector. Investors are encouraged to consider DH as a viable option for their portfolios, given its strategic initiatives and market trends. The company's innovative solutions and market demand may moderately influence its financial performance and competitive positioning.
7 Jan
Definitive Healthcare Corp. will present at the 28th Annual Needham Growth Conference, showcasing its innovative healthcare data solutions and strategic growth initiatives to investors and industry stakeholders. Participation in a prominent growth conference can enhance visibility and investor interest, potentially impacting market sentiment.
19 Dec
Definitive Healthcare Corp. (DH) is highlighted as one of three promising penny stocks with market capitalizations exceeding $10 million. The article outlines the company's potential for growth within the healthcare data analytics sector, emphasizing its innovative solutions and expanding client base. Investors are encouraged to consider DH as a viable option for those looking to invest in undervalued stocks with significant upside potential. Definitive Healthcare Corp. operates in a growing sector, but its current market position and developments suggest a limited immediate impact on its trajectory.
4 Dec
Definitive Healthcare Corp. is exploring the potential of Reddit's advertising platform to enhance its niche B2B targeting capabilities. The company aims to leverage Reddit's unique user engagement and community-driven content to create a more effective advertising strategy. This approach could provide a competitive edge in reaching specific healthcare professionals and decision-makers, ultimately driving growth and market presence. Utilizing Reddit's advertising platform may moderately enhance targeting capabilities and influence market positioning.
9 Nov
Analysts have reduced their price targets for Definitive Healthcare Corp. (NASDAQ: DH) following the company's latest financial report, indicating a shift in market sentiment and expectations regarding its future performance. Analysts adjusting price targets suggests a moderate influence on investor sentiment and potential financial performance.
7 Nov
Definitive Healthcare Corp. reported its Q3 2025 earnings, highlighting a strategic focus on growth amid challenging market conditions. The company emphasized its commitment to innovation and expanding its service offerings to enhance customer value. Key financial metrics showed a positive trajectory, with increased revenue and customer acquisition. Management addressed competitive pressures and outlined plans to navigate these challenges effectively, aiming for sustained long-term growth. Significant strategic moves and a focus on innovation are expected to impact the company's future performance and market positioning.
6 Nov
Definitive Healthcare Corp. (DH) reported better-than-expected earnings and revenue for Q3, surpassing analysts' estimates. The company's performance reflects strong demand for its healthcare data and analytics solutions, contributing to a positive outlook for future growth. Investors reacted favorably to the results, indicating confidence in the company's strategic direction and market position. Strong Q3 performance indicates significant demand for healthcare analytics, likely impacting future growth and investor sentiment.
Definitive Healthcare Corp. reported its financial results for the third quarter of fiscal year 2025, highlighting significant revenue growth and improved profitability metrics. The company attributed its success to increased demand for its healthcare data solutions and strategic partnerships. Key performance indicators showed a rise in subscription revenue and customer acquisition, positioning the company favorably in the competitive landscape. Management expressed optimism about future growth prospects and ongoing investments in technology and innovation. Strong revenue growth and strategic partnerships indicate a significant positive shift in the company's market position and future performance.